All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @mysaxendajourney2022 on TikTok · 10s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @mysaxendajourney2022's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00You

How long does a Saxenda pen last? Separating fact from TikTok

MySaxendaJourney2022

TikTok creator

238.9K viewsWatch on TikTok

Quick answer

Saxenda (liraglutide 3 mg) is a once-daily subcutaneous injection approved for chronic weight management in adults with a BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity. Each prefilled pen contains 18 mg liraglutide and the usable dose per pen varies significantly across the mandatory five-week titration schedule, from 30 days at the 0.6 mg starting dose to just six days at the 3 mg maintenance dose. Supply planning is a genuine clinical logistics issue that is frequently misunderstood, and treatment gaps can undermine both efficacy and tolerability.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For How long does a Saxenda pen last? Separating fact from TikTok, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

How long does a Saxenda pen last? Separating fact from TikTok is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "How long does a Saxenda pen last? Separating fact from TikTok" from MySaxendaJourney2022. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Saxenda (liraglutide 3 mg) is a once-daily subcutaneous injection approved for chronic weight management in adults with a BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity.

The reason this review is not generic is the source wording and the canonical claim label "glp1 reply to lynds137 thought i d reply with video as a few peop." In this clip, the useful excerpt is: "You" That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), Discontinuing glucagon-like peptide-1 receptor agonists and body habitus (2025), and Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition (2025), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The five-week dose escalation schedule (0.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Saxenda (liraglutide 3 mg) is a once-daily subcutaneous injection approved for chronic weight management in adults with a BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Saxenda (liraglutide 3 mg) is a once-daily subcutaneous injection approved for chronic weight management in adults with a BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity. Each prefilled pen contains 18 mg liraglutide and the usable dose per pen varies significantly across the mandatory five-week titration schedule, from 30 days at the 0.6 mg starting dose to just six days at the 3 mg maintenance dose. Supply planning is a genuine clinical logistics issue that is frequently misunderstood, and treatment gaps can undermine both efficacy and tolerability.
  • One Saxenda pen contains 18 mg liraglutide and lasts 30 days at 0.6 mg daily but only 6 days at the 3 mg maintenance dose.
  • The five-week dose escalation schedule (0.6 mg increasing weekly to 3 mg) means pen duration changes every week during titration.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • One Saxenda pen contains 18 mg liraglutide and lasts 30 days at 0.6 mg daily but only 6 days at the 3 mg maintenance dose.
  • The five-week dose escalation schedule (0.6 mg increasing weekly to 3 mg) means pen duration changes every week during titration.
  • A standard monthly supply at full 3 mg maintenance dose is approximately five pens, not one.
  • UK Saxenda supply was significantly disrupted between 2022 and 2024, meaning advice calibrated to pre-shortage or private prescription contexts may not apply universally.
  • Treatment gaps caused by supply miscalculation are associated with rebound weight gain and renewed GI side effects when restarting.
  • The SCALE trial showed meaningful weight loss even in patients who did not reach the full 3 mg dose, so dose escalation is not strictly binary.
  • Supply planning should be discussed with a prescribing clinician based on your current dose, not based on peer advice from social media.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What's this video probably claiming?

Based on the caption and hashtag context, this creator is almost certainly walking viewers through the practical logistics of Saxenda pen usage, specifically how many doses you get per pen and how long a prescription supply lasts at various dose stages. This is one of the most common questions in Saxenda communities, and for good reason. Saxenda (liraglutide 3 mg) comes in a 3 mL prefilled pen delivering 18 mg of liraglutide total. The answer to "how long does it last" is genuinely not straightforward because the answer changes depending on what dose titration stage you're at. A creator calling herself "Saxenda Queen UK" has likely built an audience around this kind of practical, peer-to-peer guidance. The content is probably well-intentioned. Whether the numbers being shared are accurate is a different question, and one worth examining carefully given how easy it is to miscalculate during dose escalation phases.

What does the science actually show?

Saxenda's approved dosing protocol, as established in the SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, New England Journal of Medicine), involves a mandatory titration schedule starting at 0.6 mg daily and increasing by 0.6 mg each week until reaching the 3 mg maintenance dose over five weeks. At 0.6 mg per day, one pen (18 mg total) lasts 30 days. At 3 mg per day, one pen lasts exactly six days. Most patients are somewhere in between for weeks. The arithmetic matters because under-ordering or misunderstanding supply duration leads to treatment gaps, and treatment gaps in GLP-1 therapy are associated with rebound weight gain and increased GI side effects when restarting. Novo Nordisk's own prescribing information is explicit about pen capacity, but the calculation across titration weeks is something patients are frequently left to work out themselves.

Where does the social media noise diverge from clinical reality?

The problem with peer-sourced pen duration advice on TikTok isn't usually malice, it's oversimplification. A video saying "each pen lasts about a month" is technically true at the starting dose and completely wrong at maintenance. Some creators conflate the number of pens in a monthly prescription (typically three, covering the transition from lower doses) with how long a single pen lasts at full dose. Others don't account for wasted doses from priming or injection errors, which Novo Nordisk acknowledges happens. There's also a meaningful UK-specific wrinkle: Saxenda availability through NHS was extremely limited even before the supply disruptions of 2022-2024, meaning many UK users were sourcing privately, sometimes at different pack sizes or through services with varying dispensing schedules. Advice calibrated to one supply context doesn't necessarily transfer to another, and that's rarely flagged in these videos.

What should you actually know?

Here's the actual math, which should be your reference point regardless of what any TikTok video claims. One Saxenda pen contains 18 mg liraglutide in 3 mL. At 0.6 mg daily: 30 days per pen. At 1.2 mg daily: 15 days. At 1.8 mg daily: 10 days. At 2.4 mg daily: 7.5 days. At 3 mg daily (maintenance): 6 days. A standard monthly supply at full maintenance dose is typically five pens. The SCALE trial showed that patients who did not reach the 3 mg dose still achieved meaningful weight loss, averaging around 5% body weight reduction versus 2.6% for placebo, so dose escalation is not all-or-nothing. If you're managing your Saxenda supply, plan your prescription refill based on your current dose, not the maximum dose, and not based on what worked for someone else at a different titration stage. Talk to a prescribing clinician before adjusting supply timing.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

MySaxendaJourney2022 · TikTok creator

238.9K views on this video

Reply to @lynds137 thought I’d reply with video as a few people have asked how long the pens last #saxenda #saxendajourney #saxendaweightlossjourney #weightloss #weightlossjouney #saxendauk #saxendaqueenuk #saxendalife #saxendapen

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about one saxenda pen contains 18 mg liraglutide?

One Saxenda pen contains 18 mg liraglutide and lasts 30 days at 0.6 mg daily but only 6 days at the 3 mg maintenance dose.

What does the video say about the five-week dose escalation schedule (0.6 mg increasing weekly to?

The five-week dose escalation schedule (0.6 mg increasing weekly to 3 mg) means pen duration changes every week during titration.

What does the video say about a standard monthly supply at full 3 mg maintenance dose?

A standard monthly supply at full 3 mg maintenance dose is approximately five pens, not one.

What does the video say about uk saxenda supply was significantly disrupted between 2022?

UK Saxenda supply was significantly disrupted between 2022 and 2024, meaning advice calibrated to pre-shortage or private prescription contexts may not apply universally.

What does the video say about treatment gaps caused by supply miscalculation?

Treatment gaps caused by supply miscalculation are associated with rebound weight gain and renewed GI side effects when restarting.

What does the video say about the scale trial showed meaningful weight loss even in patients?

The SCALE trial showed meaningful weight loss even in patients who did not reach the full 3 mg dose, so dose escalation is not strictly binary.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by MySaxendaJourney2022, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.